We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

You are viewing issue# 941

New slate of FTC commissioners makes early impressions

When new Federal Trade Commission member Rohit Chopra issued a memorandum scolding federal agencies for being soft on recidivists — companies that violated orders — his move made waves among long-time practitioners before the agency.


Read More

DOJ’s AT&T case ‘shrunk and shrunk,’ then disappeared

As ambitious, newly confirmed Assistant Attorney General Makan Delrahim walked through the Department of Justice’s doors last year looking to make his mark on the world of antitrust, he was greeted...

Eleventh Circuit ruling prompts debate over what’s next in LabMD saga

A much-anticipated federal appellate court ruling that vacated the Federal Trade Commission’s order requiring LabMD, a medical laboratory, to overhaul its data security program, has set off a...

‘Dragon Lady’: Lisa Phelan, trailblazer for women in antitrust, leaves DOJ after 32 years

After 32 years with the Department of Justice, Lisa Phelan — the first woman to head up a criminal team and the longest serving female chief at the antitrust division — is moving to private practice.

Dems target privacy in raising concerns on self-driving measure

The legislative effort to encourage the growth of self-driving vehicles is stalling in the Senate, largely because of issues relating to privacy and data security.  

DOJ, FTC eye competition issues in real estate market

Antitrust enforcers have grown increasingly concerned that some practices in the real estate industry restrict competition.

Neil Averitt commentary: The worrisome spin of Washington’s revolving door

The revolving door — which moves attorneys between Washington law firms and the antitrust agencies — is back in the news. This time it’s because the Democratic members at the Federal Trade...

FTC view of market in Tronox-Cristal deal ‘isn't consistent with real world,’ economist testifies

New York hearing on CVS-Aetna spotlights potential retail pharmacy vertical concerns

Bayer-Monsanto clearance shows DOJ open to negotiating on massive deals

People

Calendar